| (a) | by inserting, immediately above the item “Abciximab”, the following item:| “Abacavir; its salts; its esters; their salts”; |
|
|
| (b) | by inserting, immediately below the item “Abciximab”, the following item:| “Acamprosate; its salts”; |
|
|
| (c) | by inserting, immediately below the item “Adreno-corticotrophic hormone (ACTH)”, the following item:| “Alatrofloxacin; its salts; its esters; their salts”; |
|
|
| (d) | by inserting, immediately below the item “Azapropazone”, the following item: |
| (e) | by inserting, immediately below the item “Boric acid; sodium borate”, the following item:| “Botulinum Toxin, when contained in preparations intended for treatment of human ailments”; |
|
|
| (f) | by inserting, immediately below the item “Brimonidine; its salts”, the following item: |
| (g) | by inserting, immediately below the item “Buprenorphine; its salts”, the following item: |
| (h) | by inserting, immediately below the item “Cefuroxime”, the following item: |
| (i) | by inserting, immediately below the item “Edrophonium; its salts”, the following item: |
| (j) | by inserting, immediately below the item “Embutramide”, the following item:| “Emedastine; its salts; its esters; their salts”; |
|
|
| (k) | by inserting, immediately below the item “Enoxaparin; its salts”, the following item: |
| (l) | by inserting, immediately below the item “Epoprostenol; its salts”, the following items:| “Eprosartan; its salts; its esters; their salts |
|
|
| (m) | by inserting, immediately below the item “Flucytosine; its salts; its esters; their salts”, the following item: |
| (n) | by inserting, immediately below the item “Fosfestrol; its salts”, the following item:| “Fosfomycin; its salts; its esters and ethers; their salts”; |
|
|
| (o) | by inserting, immediately below the item “Ibacitabine”, the following item:| “Ibandronic acid; its salts”; |
|
|
| (p) | by inserting, immediately below the item “Lenograstim”, the following item: |
| (q) | by inserting, immediately below the item “Lovastatin”, the following item: |
| (r) | by inserting, immediately below the item “Mafenide; its salts”, the following item:| “Mangafodipir; its salts”; |
|
|
| (s) | by inserting, immediately below the item “Milrinone; its salts”, the following item: |
| (t) | by inserting, immediately below the item “Moclobemide”, the following item: |
| (u) | by inserting, immediately below the item “Niridazole”, the following item: |
| (v) | by inserting, immediately below the item “Orciprenaline; its salts”, the following item: |
| (w) | by inserting, immediately below the item “Oxethazaine; its salts”, the following item:| “Oxidronic acid; its salts”; |
|
|
| (x) | by inserting, immediately below the item “Oxytocins; natural and synthetic”, the following item:| “Paclitaxel; which are intended for the treatment of human ailments”; |
|
|
| (y) | by inserting, immediately below the item “Promazine; its salts”, the following item: |
| (z) | by inserting, immediately below the item “Quinine; its quarternary compounds, their salts”, the following item:| “Rabeprazole; its salts”; |
|
|
| (za) | by inserting, immediately below the item “Rafoxanide”, the following item: |
| (zb) | by inserting, immediately below the item “Rivastigmine; its salts; its esters; their salts”, the following item:| “Rizatriptan; its salts; its esters; their salts”; |
|
|
| (zc) | by inserting, immediately below the item “Rocuronium; its salts”, the following item: |
| (zd) | by inserting, immediately below the item “Rolitetracycline; its salts; its esters; their salts”, the following item: |
| (ze) | by inserting, immediately below the item “Ropivacaine; its salts”, the following item:| “Rosiglitazone; its salts”; |
|
|
| (zf) | by inserting, immediately below the item “Teicoplanin”, the following item: |
| (zg) | by inserting, immediately below the item “Thyroxine; its salts”, the following item: |
| (zh) | by inserting, immediately below the item “Topotecan; its salts”, the following item:| “Toremifene; its salts; its esters; their salts”; |
|
|
| (zi) | by inserting, immediately below the item “Tranylcypromine; its salts”, the following items: |
| (zj) | by inserting, immediately below the item “3, 4, 5-Trimethoxyamphetamine”, the following item:| “Trimetrexate; its salts; its esters; their salts”; |
|
|
| (zk) | by inserting, immediately below the item “Tropisetron; its salts”, the following item:| “Trovafloxacin; its salts; its esters; their salts”; and |
|
|
| (zl) | by inserting, immediately below the item “Zalcitabine”, the following item: |